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Abstract 
The purposes of this study were to: (1) estimate the prevalence of HIV in sexually transmitted disease (STD) clinic 
populations; (2) assess risk exposure categories associated with HIV seropositivity; (3) monitor trends; and (4) 
supply data to inform and evaluate HIV prevention programs.  Blood specimens were obtained from clients having 
routine serology at their initial visit for a new disease episode. Four clinics in Miami-Dade County participated in 
the 1990-1999 unlinked (blinded) seroprevalence survey.  Specimens routinely collected for other purposes were 
stripped of identifiers and tested for antibodies to HIV-1.  Demographic and risk information was gathered before 
testing.  Tests results and data collection forms were forwarded to the Miami-Dade County Health Department 
(MDCHD), where they were scanned and entered into a database.  We analyzed data from 41,354 specimens in 
relation to demographics, selected STDs, and HIV risk exposure categories.  Overall HIV seroprevalence was 7.5% 
with a significantly higher infection rate for men (8.3%) compared to women (6%).  Among those reporting 
heterosexual contact as their only risk, the infection rate (4.9%) was 13 times the estimated national HIV infection 
rate (0.36%).  HIV rates declined over nine years (from 10.8% to 5.8%) with significant downward trends observed 
for men and women; and for whites, blacks, and Hispanics.  We found a significantly higher HIV rate for ulcerative 
STDs (9.4%) compared with non-ulcerative STDs (6.2%) for both males and females.  Higher HIV rates were also 
found among those diagnosed with multiple STDs (15.4%) compared to those in either the ulcerative or non-
ulcerative STD category.  In conclusion, we strongly emphasize the need for assessing HIV infection in STD 
patients, and STD infections in HIV-infected patients. 
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Introduction 
Since the beginning of the AIDS epidemic, the 
incidence of HIV/AIDS has been strongly associated 
(Fleming & Wasserheit, 1999) with the co-occurrence 
of other sexually transmitted diseases (STDs).   There 
are an estimated 19 million new cases of STDs 
(Weinstock, Berman, & Cates, 2004) and 40,000 new 
HIV infections (Centers for Disease Control and 
Prevention [CDC], 2002) each year in the United 
States.   The CDC (2004) estimates that 850,000-
950,000 Americans are currently infected with HIV. 
The presence of STDs increases the likelihood 
of non-infected persons acquiring HIV infection 
through sexual contact and of HIV-infected persons 
transmitting HIV to sexual partners (CDC, 1998).  
Furthermore, sub-populations at increased risk for HIV 
transmission typically have higher rates of STDs (e.g., 
men who have sex with men (MSM) exhibit elevated 
rates of bacterial and other STDs) (CDC, 2002a).  
According to the Miami-Dade County Health 
Department (MDCHD, 2005), male-to-male sexual 
contact represented 53% of reported HIV cases among 
men in the year 2004. 
In 1987, the CDC conducted an extensive 
review of the available information on HIV prevalence 
rates in the U.S., and realized that the lack of 
standardized information by demographic subgroups 
and geographic areas made those rates difficult to 
interpret. During 1988-1989 the CDC in collaboration 
with state and local health departments, implemented a 
national serosurveillance system for HIV infection.  
This surveillance system was part of the CDC family of 
HIV seroprevalence surveys.  It used a standardized 
survey and HIV serologic testing procedures in several 
metropolitan areas throughout the U.S. (Pappaioanou, 
Dondero, Petersen, Onorato, Sanchez, & Currant, 
1990).  The present study analyzes HIV seroprevalence 
data for nine years of the CDC survey (CDC, 1990) 
conducted by the Miami-Dade County Health 
Department (MDCHD) for the period 1990-1999.  Data 
collected from four public STD clinics located in 
Miami-Dade County were examined in relation to client 
demographics, selected STDs, and self-reported HIV 
risk exposure categories. 
 
Methods 
The objectives of the STD Clinic Survey were 
to: estimate the prevalence of HIV in STD clinic 
populations; assess risk exposure categories associated 
with HIV seropositivity in these groups; monitor trends 
in infection levels and risk exposure categories over 
time; and supply data to inform and evaluate HIV 
prevention programs (CDC, 1990). 
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Survey Sites 
In Miami, four STD clinics were selected based 
on meeting the following criteria: providing STD 
services, client caseload greater than 25 per day, client 
diversity, currently conducting HIV/AIDS health 
education/risk reduction and offering HIV testing to all 
patients seeking STD services, and expressed 
willingness to participate and conduct annual surveys 
(CDC, 1990).  The predominant racial/ethnic 
composition of the zip code where the clinics were 
located is: Clinic 1, Hispanic; Clinic 2, white non-
Hispanic; Clinic 3, black non-Hispanic; and Clinic 4, 
Hispanic. 
Participants 
Clients were eligible for inclusion in the survey 
at their initial visit for a new disease episode if they had 
not visited the clinic since initiation of the annual survey 
and had blood drawn for routine purposes.  Clients were 
excluded from the survey if they were: (1) returning for 
follow-up visits for previously-diagnosed disease 
episodes in the survey period or (2) attending the STD 
clinics solely for reasons of HIV testing and counseling, 
or only for evaluation or treatment of HIV infection.  A 
client could be included in the survey if he/she presented 
for treatment of a STD and also had AIDS or HIV 
infection (CDC, 1990). 
Unlinked Surveys 
Methodological studies have demonstrated that 
participation rates for linked (confidential) surveys are 
generally lower for persons who know--or strongly 
suspect--that they are HIV infected, thereby causing the 
observed infection rate to be biased downward.  
“Unlinked” (blinded) surveys were devised to minimize 
this source of bias in the estimation of HIV 
seroprevalence.  Individuals were not informed that 
their sera would be analyzed for the presence of HIV.  
Rather, sera that were collected for routine diagnostic 
tests were tested for HIV antibodies after personal 
identifiers were removed and replaced with a unique 
survey number.  Neither the HIV test results, nor the 
information obtained from medical records could be 
linked to specific persons; hence, the term “unlinked” 
(CDC, 1990). 
Data Analysis 
For each eligible client, information routinely 
gathered during the initial visit was used to complete 
the data collection form.   This form consisted of three 
parts: (1) A laboratory report form containing the 
survey number and response grids for serologic test 
results (enzyme-linked immunosorbent assay, 
immunofluorescent assay, and Western blot); (2) A set 
of peel-off labels, each with the unique survey number 
used to code serologic specimens; and (3) A “Sexually 
Transmitted Disease Clinic Seroprevalence Survey” 
form to record date, sex, age, race/ethnicity, risk 
exposure, reason for clinic visit, HIV test history, and 
STD diagnosis (CDC, 1990). 
The data collection form was designed to be 
read by an electronic mark-sense scanner located at the 
MDCHD AIDS Program Office. Attached to the data 
collection form was a strip of labels bearing the same 
unique identification code as on the form itself.  These 
labels were affixed to the blood collection tubes and 
laboratory results were reported using the identification 
code (CDC, 1990).  Laboratory results and data 
collection forms were regularly forwarded to the 
MDCHD, where they were scanned and entered into a 
database.  Data were then sent monthly to the Florida 
Department of Health Bureau of HIV/AIDS, for editing, 
analysis, and transmittal to the CDC. 
Chi-square tests were performed to examine 
differences in proportions, differences in HIV 
seroprevalence rates, and linear time trends using Epi-
Info 2000 Version 1.1 software (Dean, 1999). 
 
Results 
From January 1990 through December 1999, 
41,354 unlinked serologic specimens were tested for 
HIV and 3,100 (7.5%) of these were HIV seropositive. 
Race / Ethnicity 
Among the 41,354 specimens analyzed, 
25,919 (62.7%) were from black non-Hispanic clients, 
11,307 (27.3%) were from Hispanic clients, 3,939 
(9.5%) were from white non-Hispanic clinic attendees, 
and 189 (0.5%) were not classified by race/ethnicity. 
This racial distribution is representative of the STD 
clinic clientele, but diverges from the Miami-Dade 
County population distribution at the time of study: 
approximately 12% black non-Hispanic, 52% Hispanic, 
30% white non-Hispanic, and 6% other race.  Overall, 
similar HIV seroprevalence rates were found for 
specimens from white non-Hispanics (7.7%) and black 
non-Hispanics (8.0%).  The white non-Hispanic rate 
was significantly higher than the rate for Hispanics 
(6.3%, p=0.001). However, when analyzed by site, site 
1 and site 2 presented significantly higher HIV 
seroprevalence rates for black non-Hispanics than for 
whites (p<0.0001). In site 3, we found a higher 
seroprevalence rate for white non-Hispanics than for 
black non-Hispanics (p=0.008).  No significant 
differences in HIV rates were found by race/ethnicity in 
site 4. 
Gender 
HIV seroprevalence for 27,333 specimens 
from men (8.3%) was significantly higher than the 
corresponding rate for specimens from 14,021 women 
(6%, p<0.0001).  This gender disparity was found for 
white non-Hispanics and Hispanics, but not for black 
non-Hispanics.  White non-Hispanic males reported the 
highest seroprevalence rate (9.6%), when compared 
with Hispanic males (8.1%, p=0.016), and black non-
Hispanic males (8.2%, p=0.01).  For specimens from 
women, a highly significant (p<0.0001) rate difference 
was observed when comparing those from black women 
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(7.7%) to those from white non-Hispanic women 
(3.7%) and Hispanic women (2.7%). When analyzed by 
site, statistically significant differences were found in 
sites 1 and 2 when comparing black non-Hispanic to 
white non-Hispanic and Hispanic men and women.  In 
site 3, white men presented a higher HIV rate than 
black non-Hispanic (p=0.0009) men.  In site 4, black 
non-Hispanics had the highest HIV seroprevalence rate 
among women. No other significant differences were 
noted. 
Age 
The highest HIV rate was observed for the age 
range 40-44 (13%).  This rate was significantly higher 
than for those <15 (3.7%, p<0.0001), 15-19 (1.7%), 20-
24 (3.1%), 25-29 (7.3%), and >45 (9%) (p<0.0001 for 
all comparisons).  Significantly higher seroprevalence 
was observed for males compared with females in these 
age groups: 35-39 (p=0.001), 40-44 (p<0.0001), and 
>45 (p<0.0001).  In the age group 40-44, the rate for 
males (15%) was almost twice the rate for females 
(8.1%).  In persons 45 and older, the rate for males 
(10.8%) was almost three times the rate for females 
(4%).  
When we analyzed the data by site, we also 
found the highest HIV rate in the 40-44 age group at 
sites 1 and 2.  These were significantly higher than all 
age ranges, excluding the 35-39 age group.  The highest 
HIV seroprevalence rate in site 3 was found in two age 
categories: 35-39 and 40-44 years old (9.3%). These 
were significantly higher than age ranges: 15-19, 20-24, 
and 25-29. Site 4 presented the highest HIV rate in the 
age category 35-39 (14.3%) a rate significantly higher 
than in the 15-19, 20-24, and > 45 age groups.  
Significantly higher seroprevalence was observed for 
males compared with females in these age groups: 25-
29 (p=0.01), 35-39 (p=0.035), 40-44, and  >45 
(p<0.0001) at site 1.  Findings were similar for the age 
group 45 and older at site 2; and for the age ranges 20-
24, 40-44, and 45 and older at site 3.  Significantly 
higher HIV rates were also found for males compared 
to females in the age groups 25-29, 30-34, 35-39, and 
>45 at site 4. 
All episodes were grouped into six sexually 
transmitted disease (STD) diagnosis categories.  The 
first two categories included “ulcerative STDs” and 
“non-ulcerative STDs.”  The next two categories were 
“STD contact” (includes all episodes when the client 
reported sexual contact with a person known to have an 
STD, was epi-treated, but reported no personal 
diagnosis of STD), and “no info/unknown.”   The last 
two categories were “other” (includes any other STD 
diagnosis not included above), and “multiple STDs” 
(includes each visit or episode when the client was 
diagnosed with two or more specific or presumptive 
STDs). 
We found a significantly higher HIV rate for 
ulcerative STDs (9.4%) compared with non-ulcerative 
STDs (6.2%, p<0.0001) for both males and females.  
Higher HIV rates (p<0.0001) were found in the 
multiple STD category (15.4%) compared to the 
ulcerative and non-ulcerative categories.  Again, this 
difference was significant for both males and females. 
The multiple STD category was associated with the 
highest seroprevalence rates for all age groups except 
<15 years (ulcerative category had the highest HIV 
rate). 
Among all the HIV-seropositive episodes for 
women, we found that 34 (97%) of the genital ulcers, 
28 (88%) of STD contacts only, 124 (83%) of the 
vaginal infections, 127 (88%) of the cases of syphilis, 
and 103 (85%) of the multiple STD diagnoses were 
reported among black-non-Hispanic women.  With 
respect to diagnoses, black non-Hispanic men 
accounted for 226 (57%) of gonorrhea, 96 (60%) of 
non-gonococcal urethritis (NGU), 201 (62%) of 
syphilis, and 130 (58%) of the multiple STD diagnoses. 
All episodes were grouped into nine HIV risk 
exposure categories.  According to CDC guidelines, the 
category “sexual contact/unknown risk” included the 
following risk exposure subcategories: heterosexual, 
received money/drugs for sex, gave money/drugs for 
sex, and smoked crack cocaine since 1978.  For 
comparison and analytical purposes we treated 
“heterosexual contact only” as a separate category. 
Among the 3,100 HIV-seropositive episodes, 
1511 (48.7%) were classified as heterosexual contact 
only, 618 (19.9%) were men who reported sex with 
men and sex with men and women (MSM/Bisexual), 
and 532 (17.1%) were classified as sexual 
contact/unknown risk. The remaining episodes 
included: 310 (10%) heterosexual partners of persons 
with a known risk for HIV, 109 (3.5%) injection drug 
users (IDUs), 20 (0.6%) MSM/Bisexual/IDUs, and 8 
(0.2%) recipients of blood or blood products. 
Heterosexual contact was the most commonly 
reported exposure.  Among 27,333 men, 19,374 
(70.8%) reported heterosexual contact only, while a 
significantly higher proportion of women reported this 
exposure (11,530 of 14,021, 82.2%, p<0.0001).  HIV 
seroprevalence rates for these 19,374 men (5.1%) and 
11,530 women (4.5%) also were significantly different 
(p=0.018).  Whereas these rates exceed the 1997 
estimated HIV infection rate in the adult/adolescent 
population of Miami-Dade County (25,600 HIV 
seropositive/2.0 million=1.3%), they serve as baseline 
seroprevalence rates for comparing infection rates for 
all other identified risk exposure categories. 
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 Table 1. HIV Seroprevalence among STD clinic clients by site, gender and race/ethnicity     
 Miami/Dade County, Florida, 1990-1999           
                 
    
SITE 
1    
SITE 
2    
SITE 
3    
SITE 
4    
ALL 
SITES   
   Number HIV+ Rate Number HIV+ Rate Number HIV+ Rate Number HIV+ Rate Number HIV+ Rate 
                       
White Male 807 59 7.31 264 8 3.03 494 44 8.9 1117 147 13.16 2682 258 9.61 
 Female 401 17 4.23 155 8 5.16 250 8 3.2 451 14 3.1 1257 47 3.73 
 Subtotal 1208 76 6.29 419 16 3.81 744 52 6.98 1568 161 10.26 3939 305 7.74 
Black Male 8311 798 9.6 2343 212 9.04 5628 300 5.33 693 74 10.67 16975 1384 8.15 
 Female  4526 448 9.89 978 107 10.94 3096 118 3.81 344 20 5.81 8944 693 7.74 
 Subtotal 12837 1246 9.7 3321 319 9.6 8724 418 4.79 1037 94 9.06 25919 2077 8.01 
Hispanic Male 4510 370 8.2 951 37 3.89 734 48 6.53 1349 157 11.63 7544 612 8.11 
 Female 2628 67 2.54 234 11 4.7 369 8 2.16 532 16 3 3763 102 2.71 
 Subtotal 7138 437 6.12 1185 48 4 1103 56 5.07 1881 173 9.19 11307 714 6.31 
Other Male 93 3 3.22 7 1 14.28 15 0 0 17 0 0 132 4 3.03 
 Female 34 0 0 1 0 0 11 0 0 11 0 0 57 0 0 
 Subtotal 127 3 2.36 8 1 12.5 26 0 0 28 0 0 189 4 2.12 
                       
                       
All races Male 13721 1230 8.96 3565 258 7.23 6871 392 5.7 3176 378 11.9 27333 2258 8.26 
 Female 7589 532 7.01 1368 126 9.21 3726 134 3.59 1338 50 3.73 14021 842 6 
 Total 21310 1762 8.26 4933 384 7.78 10597 526 4.96 4514 428 9.48 41354 3100 7.49 
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Table 2. HIV Seroprevalence among STD Clinic Clients by Selected Sexual Transmitted Diseases and Gender  
Miami/Dade County, Florida, 1990-1999          
             
   Males    Females    Total  
  Number  HIV+ Rate/100  Number HIV+ Rate/100  Number HIV+ Rate/100 
             
Ulcerative STDs            
Syphilis  2260 324 14.3  1412 146 10.3  3672 470 12.8 
Genital Ulcers/Herpes 6184 470 7.6  509 35 6.9  6693 505 7.5 
Genital Warts 102 6 5.9  47 4 8.5  149 10 6.7 
Sub-total  8546 800 9.4  1968 185 9.4  10514 985 9.4 
             
Non-ulcerative STDs            
Gonorrhea  5033 397 7.9  1195 64 5.4  6228 461 7.4 
NGU/cervicitis/chlamydia 2486 161 6.5  949 43 4.5  3435 204 5.9 
PID  0 0 0.0  3407 150 4.4  3407 150 4.4 
Penile/vaginal discharge 238 15 0.0  136 10 7.4  374 25 6.7 
Sub-total  7757 573 7.4  5687 267 4.7  13444 840 6.2 
             
Other STDs 3952 315 8.0  2333 154 6.6  6285 469 7.5 
STD Contact  1822 113 6.2  938 32 3.4  2760 145 5.3 
No Info/Unknown 3933 233 5.9  2178 83 3.8  6111 316 5.2 
Multiple STDs 1323 224 16.9  917 121 13.2  2240 345 15.4 
             
Total  27333 2258 8.3  14021 842 6.0  41354 3100 7.5 
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Table 3. HIV Seroprevalence among STD Clinic Clients by Risk Exposure Categories and Gender   
               Miami/Dade County, Florida, 1990-1999       
          
  Male   Female   Total  
 Number HIV+ Rate Number HIV+ Rate Number HIV+ Rate 
MSM/Bisexual 2,217 618 27.9 0 0 0.0 2,217 618 27.9 
IDU 316 70 22.2 178 39 21.9 494 109 22.1 
MSM/Bisexual/IDU 52 20 38.5 0 0 0.0 52 20 38.5 
Heterosexual, partner at risk 
HIV 1,431 165 11.5 1,091 136 12.5 2,522 301 11.9 
Blood Recipient* 68 4 5.9 48 4 8.3 116 8 6.9 
Hemophilia* 2 0 0.0 0 0 0.0 2 0 0.0 
Sexual contact/unknown risk 3,851 390 10.1 1,132 142 12.5 4,983 532 10.7 
Undetermined* 22 1 4.5 42 0 0.0 64 1 1.6 
          
Heterosexual contact only 19,374 990 5.1 11,530 521 4.5 30,904 1,511 4.9 
          
Total 27,333 2,258 8.3 14,021 842 6.0 41,354 3,100 7.50 
          
* No significant P value for comparison of the risk specific seroprevalence rate to the baseline   
  heterosexual contact risk-only rate           
 
For both sexes combined, and excluding blood 
recipient, hemophilia, and the undetermined category, 
highly significant elevations of HIV seroprevalence 
above the heterosexual-contact-only baseline rate were 
found for each of the exposure categories. Moreover, 
statistically significant differences between men and 
women were found for all of the risk exposure 
categories for which seropositivity rates were available 
for both sexes, with the exception of the IDU category 
(p=0.95).  
A significantly higher proportion of men 
reported sexual contact/unknown risk (19.8% for men, 
9.8% for women, p<0.0001), whereas a significantly 
higher proportion of women reported heterosexual 
partner at risk for HIV (9.5% for women, 7.4% for men, 
p<0.0001). 
When compared by race, black non-Hispanics 
had significantly (p<0.0001) higher HIV rates for three 
of eight risks assessed on the behavioral survey 
compared with clients of all other race/ethnicities.  
These risks included gay/bisexual male, IDU, and 
sexual contact/unknown risk.   Compared with all other 
races, significantly (p<0.0001) higher proportions of 
black non-Hispanics reported engaging in four 
behavioral risks: gay/bisexual, IDU, heterosexual 
partner at risk of HIV, and sexual contact/unknown 
risk. 
A highly significant decline in HIV infection 
rates was observed across the nine full-year annual 
cycles of data collection (see Figure 1), from 10.83% in 
1990 to 5.79% in 1999 (p<0.0001).   This significant 
decrease in seroprevalence was found for both men 
(p<0.0001) and women (p<0.0001) as well as for white 
non-Hispanics, black non-Hispanics, and Hispanics 
(p<0.0001).  Significant downward time trends were 
also found among the three race/ethnicity groups when 
analyzed by gender, except for white non-Hispanic 
females (p=0.692). 
Figure 1. HIV  Seroprevalence among STD clinic clients by race/ethnicity and year. 
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The proportion of Hispanics included in the 
survey increased from 23% in 1990 to 27% in 1999 
(p<0.0001).  A significant downward time trend was 
observed for black non-Hispanics, with their proportion 
decreasing from 68% in 1990 to 63% in 1999 
(p<0.0001).  The proportion of white non-Hispanics 
included also showed a downward time trend, 
decreasing from 9% in 1990 to 4% in 1999.  With 
respect to risk exposure categories, significant 
downward trends were observed for the proportion of 
IDU only.  However, a significant downward trend in 
HIV seroprevalence was found for the risk exposure 




In this study, the standardized national 
protocol facilitates estimation of HIV seroprevalence 
among clients attending sexually transmitted disease 
clinics. However, data from this survey have several 
limitations. First, the data was collected from patients at 
increased risk for HIV who chose to seek medical care 
at the STD clinic serving this population, and whose 
initial visit during an annual survey cycle included 
blood collection for routine serologic tests.   Therefore, 
the patients attending these clinics are not 
representative of all persons with STDs (e.g., those seen 
by a private physician, those asymptomatic, etc.) and 
their seroprevalence data serve as indicators rather than 
representative estimates of HIV infection in Miami’s 
STD-infected persons.   Second, changing patterns of 
attendance in STD clinics are a potential source of bias. 
 For example, HIV-positive patients may be more likely 
to seek health care in other medical settings, and thus, 
their loss from the STD clinic population could give a 
false decreasing prevalence. As counterpoints to 
potential sources of bias, the unlinked (blinded) survey 
design, the criteria used for the selection of the four 
STD clinics, and the high number of participants 
strengthen the validity of the results. 
HIV Seroprevalence and Risk  
Exposure Category 
This study corroborates the results of previous 
and similar studies.  Our study found that HIV infection 
rates were higher among those STD clients who 
reported behaviors already associated with increased 
risk for HIV infection.  Among those reporting 
heterosexual contact only, the HIV seroprevalence rate 
(4.9%) was almost four times the estimated HIV rate 
for the Miami-Dade County adult/adolescent population 
(1.3%), and about 13 times the national HIV infection 
rate of 0.36% (Karon, Rosenberg, McQuillan, Khare, 
Gwinn, & Petersen, 1996).   
For STD clinic clients reporting one or more 
specified risk exposures, HIV seroprevalence rates were 
significantly higher than the baseline rate for 
heterosexual contact only clients.   In particular, 
gay/bisexual male, IDU, heterosexual partner at risk for 
HIV, and sexual contact/unknown risk were each 
associated with highly significant elevations of HIV 
seropositivity rates above the baseline heterosexual 
rate. 
A distinguishing finding of the Miami STD 
clinic survey was that there were almost no differences 
in seroprevalence noted between men and women for 
risk exposure categories when seropositivity rates were 
available for both genders.  The only exceptions were 
the sexual contact/unknown risk category, where the 
rate for females was statistically higher than the rate for 
males, and the heterosexual contact only category 
where the rate for males was higher than the rate for 
females.  Interestingly, the proportion of women in the 
sexual contact/unknown category was statistically 
lower than that for men.  
Significantly higher rates of HIV infection 
were found for black non-Hispanics than for Hispanics 
and white non-Hispanics in the following risk exposure 
categories: gay/bisexual male, IDU, and sexual 
contact/unknown risk.  Because the majority of HIV-
infected clients reported heterosexual contact only, 
further discussion of heterosexual transmission of HIV 
among STD patients is warranted.   Heterosexual sex is 
a prevalent behavior and a significantly higher 
proportion of HIV seronegatives (71.9%) reported 
heterosexual contact only compared with seropositives 
(38.1%, p<0.001).   Comparisons presented in Table 3 
indicate that all specified sexual and substance use risk 
exposures added significant increments to HIV 
seroprevalence above the heterosexual contact only.   
Finally, the high prevalence of sexually transmitted 
diseases among the STD clinic clients who reported 
heterosexual contact only enhances sexual transmission 
of HIV. 
HIV Seroprevalence and Type of STD 
Consistent with the concern that STDs 
facilitate the transmission of HIV, we hypothesized that 
STD clinic clients with non-ulcerative STDs would 
have lower HIV seropositivity rates than clients with 
ulcerative or multiple STDs. The study results 
corroborated these expectations.   Overall and by 
gender, we found a statistically significant difference 
between the higher seroprevalence rate found in the 
multiple STD category and the lower seroprevalence 
rates of the ulcerative and non-ulcerative STDs 
categories. 
A particular characteristic of Miami’s STD 
clinic population was the overrepresentation of HIV 
seropositive episodes among black non-Hispanic 
women in several STD diagnosis categories (vaginal 
infections caused by trichomonas, syphilis and genital 
ulcers). This is important because of the asymptomatic 
nature of many STDs, particularly in the absence of 
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regular STD screening.  This could result in significant 
secondary morbidity (cancer, infertility, ectopic 
pregnancy, spontaneous abortions, stillbirth, low birth-
weight for infants) and higher likelihood of acquiring or 
transmitting HIV.  
STD prevention and control in public health 
settings has focused on surveillance, screening, partner 
notification, and treatment.  Nevertheless, it is advisable 
to put in practice interventions that prevent STDs from 
occurring since many are not symptomatic and not 
curable.   Involvement of the private sector is urgent.  
According to the CDC only 5% of those individuals 
who reported having been treated for a STD sought care 
in a publicly funded STD clinic (Brackbill, Sternberg, 
& Fishbein, 1999).  Increasing the number of 
professional experts in the field of behavioral and social 
sciences at the state and local level would also be 
beneficial.  If we are to design and implement effective 
public health strategies to prevent and control STDs we 
need to understand their mode of transmission and the 
attached behavioral and cultural attitudes.  Finally, the 
amount of economic resources allocated to STD 
research and prevention should be increased.  The costs 
of the major STDs - not including HIV infection – and 
their complications add at least $10 billion to the 
nation’s health care costs each year (Cason, Orrock, 
Tesoriero, Lazzarini, & Sumartojo, 2002). 
Time Trends: Decreasing HIV  
Seroprevalence Over Time 
A significant decrease in HIV seroprevalence 
was observed over the nine-year survey period from 
10.83% in 1990 to 5.79% in 1999.  Decreasing trends 
have also been observed at the national level (CDC, 
2001).  Seeking to understand this drop in 
seroprevalence, we noted two significant demographic 
shifts toward lower-risk clinic clients: a decreasing 
proportion of black non-Hispanic clients, and 
increasing proportion of Hispanic and white non-
Hispanic clients.   
The progression of the HIV epidemic and 
availability of HIV health services may have led to 
some selective “removal” of those at highest risk: 
because they died from HIV disease, or entered HIV 
treatment trials and/or received medical care elsewhere. 
Recommendations for STD Clinics and  
Local Health Departments 
 STD clinics are useful settings for evaluating 
HIV prevention programs because they provide services 
to patients at increased risk for HIV.  They are also an 
excellent venue for delivering prevention messages and 
conducting STD screening (Backmann, Grimley, 
Waithaka, Desmond, Saag, & Hook, 2005).  
 We strongly agree with the CDC‘s Advisory 
Committee on HIV and STD Prevention, in that: (1) 
early detection and treatment of curable STDs must be 
an integral part of comprehensive HIV prevention 
programs; (2) in areas where STDs that facilitate HIV 
transmission are prevalent, screening and treatment 
programs should be expanded; and (3) HIV and STD 
prevention programs, together with the private and 
public sector, should take joint responsibility for 
implementing these strategies (CDC, 1998). 
Finally, we believe that a strengthened 
collaboration between the HIV and STD programs is of 
vital importance.  In this regard, the CDC’s HIV/STD 
Collaboration Workshop has given some useful 
recommendations: (1) Share funding and personnel 
between STD and HIV; (2) cross-training of staff in 
HIV and STD; (3) HIV counseling, testing, and partner 
notification made available through the STD program; 
and (4) providing referrals to HIV counseling and 
testing at local STD clinics (CDC, 1998a). 
Public Health Implications 
 All patients with a STD diagnosis should be 
questioned about risk factors for HIV infection.  
Whether or not risk factors for HIV are elicited, STD 
patients should be urged to have an HIV test performed 
because a person with an STD is at increased risk of 
HIV infection.  Ulcerative STDs facilitate entry for 
HIV, and non-ulcerative STDs increase the 
concentration of targeting CD4 cells in genital 
secretions.  Similarly, a person with an STD and HIV 
infection may be more infectious. An HIV-infected 
patient with another STD is more likely to shed HIV in 
their genital secretions than someone who is infected 
only with HIV.  
 Therefore, early diagnosis and treatment of 
STDs can reduce both susceptibility to HIV infection, 
and infectiousness among those already HIV infected.  
Furthermore, confirming a diagnosis of HIV/AIDS 
establishes eligibility for certain social, medical, and 
economic benefits for the patient. 
 
Conclusion 
 Among patients treated in Miami-Dade County 
STD clinics during the survey period, 7.5% were 
infected with HIV.  For STD clinic patients reporting 
heterosexual contact as the only behavioral risk, 1 in 20 
were HIV infected, while for those clients reporting 
specific sexual or drug use risks for HIV, the likelihood 
of HIV infection increased to 1 in 5.  We emphasize the 
need for assessing HIV infection in STD patients, and 
STD infections in HIV-infected patients.    
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